0001973379-24-000088.txt : 20240304
0001973379-24-000088.hdr.sgml : 20240304
20240304151738
ACCESSION NUMBER: 0001973379-24-000088
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Ascendis Pharma A/S
CENTRAL INDEX KEY: 0001612042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-36815
FILM NUMBER: 24714651
BUSINESS ADDRESS:
STREET 1: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
BUSINESS PHONE: 45 70 22 22 44
MAIL ADDRESS:
STREET 1: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: RASMUSSEN PETER
CENTRAL INDEX KEY: 0001965571
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O ASCENDIS PHARMA A/S
STREET 2: TUBORG BOULEVARD 12
CITY: HELLERUP
STATE: G7
ZIP: DK-2900
144
1
primary_doc.xml
144
0001965571
XXXXXXXX
LIVE
0001612042
Ascendis Pharma A/S
001-36815
TUBORG BOULEVARD 12
HELLERUP
G7
DK-2900
45 70 22 22 44
RASMUSSEN PETER
Officer
Principal Accounting Officer & VP Finance
Ordinary Shares
Citigroup Global Markets Inc.
390 Greenwich Street
New York
NY
10013
677
101550.00
57707439
03/01/2024
NASDAQ
Ordinary Shares
03/01/2024
Restricted Stock Vesting
Ascendis Pharma A/S
N
1200
03/01/2024
Services Rendered
Y
The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting.
03/04/2024
Conformed Signature on File